Trexquant Investment LP Blueprint Medicines Corp Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Trexquant Investment LP holds 118,545 shares of BPMC stock, worth $10.7 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

118,545

Previous 133,243 11.03%

Holding current value

$10.7 Million

Previous $14.4 Million 23.68%

% of portfolio

0.14%

Previous 0.23%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$84.1 - $120.5 $1.24 Million - $1.77 Million	-14,698 Reduced 11.03%	118,545 $11 Million
Q2 2024 Aug 13, 2024	BUY	$85.18 - $108.78 $11.2 Million - $14.2 Million	130,946 Added 5700.74%	133,243 $14.4 Million
Q1 2024 May 14, 2024	SELL	$73.17 - $99.79 $4 Million - $5.45 Million	-54,635 Reduced 95.97%	2,297 $217,000
Q4 2023 Feb 09, 2024	BUY	$43.96 - $92.84 $2.5 Million - $5.29 Million	56,932 New	56,932 $5.25 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $4.32 Million - $6.72 Million	86,523 Added 1602.57%	91,922 $6.06 Million
Q2 2022 Aug 11, 2022	BUY	$45.23 - $70.15 $244,196 - $378,739	5,399 New	5,399 $273,000
Q4 2020 Feb 11, 2021	SELL	$92.08 - $124.48 $378,356 - $511,488	-4,109 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$66.45 - $92.7 $580,042 - $809,178	-8,729 Reduced 67.99%	4,109 $381,000
Q2 2020 Aug 07, 2020	SELL	$57.09 - $79.27 $1.23 Million - $1.71 Million	-21,585 Reduced 62.71%	12,838 $1 Million
Q1 2020 May 08, 2020	BUY	$48.11 - $82.22 $1.52 Million - $2.59 Million	31,513 Added 1082.92%	34,423 $2.01 Million
Q4 2019 Feb 12, 2020	BUY	$66.73 - $82.59 $194,184 - $240,336	2,910 New	2,910 $233,000
Q3 2019 Nov 08, 2019	SELL	$72.9 - $101.41 $157,172 - $218,639	-2,156 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$73.54 - $97.8 $158,552 - $210,856	2,156 New	2,156 $203,000
Q1 2019 May 13, 2019	SELL	$48.7 - $86.6 $1.35 Million - $2.41 Million	-27,774 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$45.57 - $74.26 $304,453 - $496,131	6,681 Added 31.67%	27,774 $1.5 Million
Q3 2018 Nov 09, 2018	BUY	$58.91 - $78.32 $1.24 Million - $1.65 Million	21,093 New	21,093 $1.65 Million
Q2 2018 Aug 07, 2018	SELL	$60.96 - $101.18 $1.18 Million - $1.95 Million	-19,279 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$73.28 - $102.95 $1.41 Million - $1.98 Million	19,279 New	19,279 $1.77 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Blueprint Medicines Corp Transaction History